Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies

Noradrenergic dysfunction contributes to cognitive impairment in Alzheimer's Disease (AD) and Parkinson's Disease (PD). Conventional therapeutic strategies seek to enhance cholinergic and dopaminergic neurotransmission in AD and PD, respectively, and few studies have examined noradrenergic dysfuncti...

Descripció completa

Dades bibliogràfiques

Autors principals:	Andrew C. Peterson, Chiang-shan R. Li
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2018-05-01
Col·lecció:	Frontiers in Aging Neuroscience
Matèries:	norepinephrine dopamine neurodegeneration neurodegenerative locus coeruleus ventral tegmental area
Accés en línia:	http://journal.frontiersin.org/article/10.3389/fnagi.2018.00127/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!